Evidence map›Paper›PMID 25324519›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2015

Cardiac troponin I Pro82Ser variant induces diastolic dysfunction, blunts β-adrenergic response, and impairs myofilament cooperativity.

Genaro A Ramirez-Correa, Aisha H Frazier, Guangshuo Zhu, Pingbo Zhang, Thomas Rappold, Viola Kooij, Djahida Bedja, Greg A Snyder, Nahyr S Lugo-Fagundo, Raena Hariharan and 7 more

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Genaro A Ramirez-CorreaDepartment of Pediatrics and Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Aisha H FrazierDepartment of Pediatrics and Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Guangshuo ZhuDepartment of Medicine and Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Pingbo ZhangThe Hopkins Bayview Proteomics Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Thomas RappoldThe Hopkins Bayview Proteomics Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Viola KooijThe Hopkins Bayview Proteomics Center, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Djahida BedjaDepartment of Comparative Medicine and Comparative Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Greg A SnyderInstitute of Human Virology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Nahyr S Lugo-FagundoDepartment of Pediatrics and Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Raena HariharanDepartment of Pediatrics and Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Yuejin LiDepartment of Pediatrics and Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Xiaoxu ShenDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.
Wei Dong GaoDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.
Oscar H CingolaniDepartment of Medicine and Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Eiki TakimotoDepartment of Medicine and Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
D Brian FosterDepartment of Medicine and Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Anne M MurphyDepartment of Pediatrics and Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland; murphy@jhmi.edu.

Funding

MOLECULAR PHYSIOLOGY OF MYOCARDIAL TROPONIN I VARIANTSR01HL063038 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MURPHY, ANNE M · 1999 to 2018
$6.2M
NHLBI NIH HHS HHSN268201000032CNHLBI NIH HHS R01 HL063038NHLBI NIH HHS R01-HL-63038NICHD NIH HHS T32HD4435
6 · The paper itself

Abstract

Troponin I (TnI) variant Pro82Ser (cTnIP82S) was initially considered a disease-causing mutation; however, later studies suggested the contrary. We tested the hypothesis of whether a causal link exists between cTnIP82S and cardiac structural and functional remodeling, such as during aging or chronic pressure overload. A cardiac-specific transgenic (Tg) mouse model of cTnIP82S was created to test this hypothesis. During aging, Tg cTnIP82S displayed diastolic dysfunction, characterized by longer isovolumetric relaxation time, and impaired ejection and relaxation time. In young, Tg mice in vivo pressure-volume loops and intact trabecular preparations revealed normal cardiac contractility at baseline. However, upon β-adrenergic stimulation, a blunted contractile reserve and no hastening in left ventricle relaxation were evident in vivo, whereas, in isolated muscles, Ca(2+) transient amplitude isoproterenol dose-response was blunted. In addition, when exposed to chronic pressure overload, Tg mice show exacerbated hypertrophy and decreased contractility compared with age-matched non-Tg littermates. At the molecular level, this mutation significantly impairs myofilament cooperative activation. Importantly, this occurs in the absence of alterations in TnI or myosin-binding protein C phosphorylation. The cTnIP82S variant occurs near a region of interactions with troponin T; therefore, structural changes in this region could explain its meaningful effects on myofilament cooperativity. Our data indicate that cTnIP82S mutation modifies age-dependent diastolic dysfunction and impairs overall contractility after β-adrenergic stimulation or chronic pressure overload. Thus cTnIP82S variant should be regarded as a disease-modifying factor for dysfunction and adverse remodeling with aging and chronic pressure overload.

Indexed as

AgingAmino Acid SubstitutionAnimalsDiastoleFemaleHeartHeart DiseasesHypertrophyIn Vitro TechniquesMaleMiceMice, TransgenicMyocardiumReceptors, Adrenergic, betaStress, PhysiologicalTroponin IReceptors, Adrenergic, betaTroponin Icardiac troponin I mutationdiastolic dysfunctionhypertrophytransgenic mouse

Identifiers

PMID25324519
PMCPMC4297775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.